|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
107,850,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
86,766 |
258,293 |
423,430 |
589,230 |
Total Sell Value |
$5,938,218 |
$18,083,575 |
$27,078,360 |
$31,583,563 |
Total People Sold |
5 |
7 |
7 |
9 |
Total Sell Transactions |
12 |
32 |
52 |
80 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Eydelman Mikhail |
SVP, GEN COUNSEL & CORP SEC |
|
2024-07-01 |
4 |
AS |
$75.93 |
$127,304 |
D/D |
(1,667) |
30,826 |
|
- |
|
Eydelman Mikhail |
SVP, GEN COUNSEL & CORP SEC |
|
2024-07-01 |
4 |
OE |
$21.41 |
$35,690 |
D/D |
1,667 |
32,493 |
|
- |
|
Wassil Jim |
CHIEF OPERATING OFFICER |
|
2024-07-01 |
4 |
AS |
$75.75 |
$229,013 |
D/D |
(3,000) |
210,503 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-07-01 |
4 |
AS |
$75.84 |
$199,690 |
I/I |
(2,616) |
143,438 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2024-06-18 |
4 |
AS |
$71.89 |
$575,375 |
D/D |
(8,000) |
96,720 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2024-06-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
104,720 |
|
- |
|
Eydelman Mikhail |
SVP, GEN COUNSEL & CORP SEC |
|
2024-06-07 |
4 |
D |
$70.97 |
$23,775 |
D/D |
(335) |
30,826 |
|
- |
|
Gilbert Halley E |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
7,175 |
|
- |
|
Paya Carlos V |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
4,050 |
|
- |
|
Drapeau Anne S |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
7,175 |
|
- |
|
Loxam Teri |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
7,175 |
|
- |
|
Lukatch Heath |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
7,175 |
|
- |
|
Hirth Peter |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
7,175 |
|
- |
|
Lee Jacks |
Director |
|
2024-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,550 |
1,550 |
|
- |
|
Wassil Jim |
CHIEF OPERATING OFFICER |
|
2024-06-03 |
4 |
AS |
$71.38 |
$215,961 |
D/D |
(3,000) |
213,503 |
|
- |
|
Gilbert Halley E |
|
|
2024-06-03 |
4 |
AS |
$73.00 |
$1,328,600 |
D/D |
(18,200) |
5,625 |
|
- |
|
Gilbert Halley E |
|
|
2024-06-03 |
4 |
OE |
$5.35 |
$97,370 |
D/D |
18,200 |
23,825 |
|
- |
|
Eydelman Mikhail |
SVP, GEN COUNSEL & CORP SEC |
|
2024-06-03 |
4 |
AS |
$71.25 |
$120,127 |
D/D |
(1,667) |
31,161 |
|
- |
|
Eydelman Mikhail |
SVP, GEN COUNSEL & CORP SEC |
|
2024-06-03 |
4 |
OE |
$21.41 |
$35,690 |
D/D |
1,667 |
32,828 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-06-03 |
4 |
AS |
$71.43 |
$188,512 |
I/I |
(2,616) |
144,746 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-05-23 |
4 |
AS |
$68.84 |
$1,041,408 |
D/D |
(15,000) |
477,847 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-05-23 |
4 |
OE |
$2.03 |
$30,450 |
D/D |
15,000 |
492,847 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2024-05-20 |
4 |
AS |
$74.40 |
$599,909 |
D/D |
(8,000) |
95,679 |
|
- |
|
Guggenhime Andrew |
PRESIDENT AND CFO |
|
2024-05-20 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
103,679 |
|
- |
|
Pickering Grant |
CHIEF EXECUTIVE OFFICER |
|
2024-05-01 |
4 |
AS |
$61.25 |
$161,419 |
I/I |
(2,616) |
146,054 |
|
- |
|
377 Records found
|
|
Page 1 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|